Edmond DE Rothschild Holding S.A. Buys Shares of 78,400 The Cooper Companies, Inc. $COO

Edmond DE Rothschild Holding S.A. bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, Holdings Channel reports. The firm bought 78,400 shares of the medical device company’s stock, valued at approximately $5,622,000.

Other hedge funds have also recently made changes to their positions in the company. New York Life Investment Management LLC grew its stake in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after buying an additional 158 shares during the last quarter. Root Financial Partners LLC raised its stake in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the last quarter. Essential Partners LLC raised its stake in Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after buying an additional 166 shares during the last quarter. Allworth Financial LP boosted its holdings in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of COO opened at $76.73 on Thursday. The company has a market cap of $14.96 billion, a price-to-earnings ratio of 65.03, a P/E/G ratio of 1.98 and a beta of 0.83. The business’s fifty day simple moving average is $71.59 and its two-hundred day simple moving average is $71.16. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on COO. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Robert W. Baird reduced their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. Finally, Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.